Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...
Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.
SES Force-4, a division of premium engineering services provider Stress Engineering Services, will exhibit at DeviceTalks ...
C Medical Technologies announced today that it closed a Series D financing round resulting in gross proceeds of up to $175 ...
Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ...
Hosted on MSN2mon
Here’s Why Boston Scientific Corp. (BSX) Skyrocketed TodayBoston Scientific Corp. (NYSE ... Bolt Medical is focused on the design and development of laser-based IVL catheters used in coronary and peripheral interventional procedures, particularly in ...
In the closing of the recent trading day, Boston Scientific (BSX) stood at $95.52, denoting a +1.48% change from the preceding trading day. Boston Scientific (NYSE:BSX) recently experienced a 4% ...
Boston Scientific (BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment.
Boston Scientific stock (NYSE: BSX) has gained 3% in the five days since its Q4 earnings report last week. Although the company exceeded expectations with both its results and guidance ...
(RTTNews) - Boston Scientific Corp. (BSX), Monday announced its decision to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System.
Boston Scientific has gained a duo of CE markings in the European Union (EU) for its navigation enabled Farawave NAV Ablation Catheter for paroxysmal atrial fibrillation (AF) treatment and its new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results